Curia vs CytoReason
Curia vs CytoReason, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Curia is on 67/100 and CytoReason on 68/100.
Where each one leads
Curia
- agent readiness: 49/100 against 21/100
- domain rating: 52/100 against 40/100
- headcount: 3,386 against 116
- LinkedIn following: 108,433 against 12,830
CytoReason
- funding raised: $128M against $56.3M
At a glance
| Measure | Curia | CytoReason |
|---|---|---|
| What it is | Global contract research, development, and manufacturing organization for pharmaceutical and biopharmaceutical industries. | Develops a computational model of the human body for drug discovery and development. |
| Category | Contract Research Organization, Contract Development and Manufacturing Organization (CDMO), Drug Discovery, Drug Development | Healthcare, Drug Discovery, Clinical Development, Biomarkers |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Software |
| Founded | 1991 | 2016 |
| Headquarters | Albany, United States | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | Curia | CytoReason |
|---|---|---|
| Employees | 3,386 | 116 |
| Headcount growthLast 12 months | Not published | +13.7% |
| Total funding | $56.3M | $128M |
| Latest round | IPO | Series B |
| LinkedIn followers | 108,433 | 12,830 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Curia | CytoReason |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 67/100 | 68/100 |
| Traction | 59/100 | 60/100 |
| Team | 70/100 | 70/100 |
| Search visibility | 38/100 | 30/100 |
| Quality | 78/100 | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (49/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 52/100 | 40/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Curia | CytoReason |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Not detected |
| Analytics | Google Tag Manager, Microsoft Clarity, Linkedin Insight | Segment |
| Support stack | HubSpot | Not detected |
Curia vs CytoReason: common questions
Which is better, Curia or CytoReason?
On our 0-100 score CytoReason rates higher (68/100 against 67/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do Curia and CytoReason compare on the numbers?
Curia leads on agent readiness (49/100 against 21/100), domain rating (52/100 against 40/100), headcount (3,386 against 116), LinkedIn following (108,433 against 12,830). CytoReason leads on funding raised ($128M against $56.3M).
Read the full Curia review and pricing or the CytoReason review and pricing. You can also browse other Curia alternatives we track.